Therapeutic areas

Nova’s influenza model accounts for the interplay between a viral infection and vaccination. It describes the key pathways and biomarkers influencing vaccine efficacy...

Nova’s Asthma model describes the immune response following a provocation by an allergen and leading to airway inflammation and subsequent decrease of lung functions.

Nova’s atopic dermatitis (AD) model accounts for the interplay between the skin barrier and the immune system. It describes the key pathways and biomarkers influencing disease course...

Nova's non small cell lung cancer (NSCLC) disease model of epidermal growth factor receptor (EGFR) mutant lung adenocarcinoma (LUAD)

Nova’s hepatitis B disease (HBV) model accounts for the virus pathophysiology, including viral replication within hepatocytes and antiviral immune response in chronically infected patients.